Hormone therapy in Quebec: what RAMQ covers

When hormone therapy is being considered to ease perimenopause or menopause symptoms, one question often comes up: is it covered by RAMQ?

In Quebec, the answer depends mainly on the medication prescribed, the formulation, and whether it appears on the List of medications. This article clarifies the main principles. It does not replace verification with your pharmacist.

At a glance

• In Quebec, coverage for hormone therapy depends mainly on whether the product is listed on the List of medications and on the conditions of the public prescription drug insurance plan.
• Since 2022, access has been made easier for certain commonly used bioidentical hormones, notably estradiol-17β gel and micronized progesterone.
• Not all formulations are covered in the same way: patches, tablets, gels, local treatments, or compounded preparations may differ.
• Systemic hormone therapy and local hormone therapy do not address the same clinical needs; their coverage should also be verified separately.
• The best way to confirm whether a specific product is covered remains checking with the pharmacy.

What exactly are we talking about?

It is important to distinguish:

1. Coverage for the medications prescribed for hormone therapy
2. Consultation or clinical assessment fees

This article focuses only on medications.

It is also useful to distinguish:

• Systemic hormone therapy, which acts throughout the body (for example for hot flashes or night sweats)
• Local hormone therapy, often vaginal, used mainly for genitourinary symptoms of menopause

These options are not interchangeable. Their coverage may also differ.

Who is covered by the public plan?

In Quebec, everyone generally must be covered by a prescription drug insurance plan:

• the public plan administered by RAMQ, or
• a private plan, often linked to employment or a spouse

If you have private insurance, it usually applies first. The rules may then differ from those of the public plan. The rest of this article focuses on the logic of the public plan and the List of medications.

The public plan does not automatically cover every medication. It mainly covers those listed on the List of medications, when they are prescribed by an authorized health professional and obtained from a pharmacy in Quebec, according to the plan’s conditions.

Regular list vs exception drugs: why it matters

On the List of medications, a useful distinction is:

• medications on the regular list, generally covered under the plan’s usual conditions
• exception drugs, which may be covered only if certain conditions are met

This distinction matters a great deal in hormone therapy. Even if a treatment is appropriate for your symptoms, its coverage may be more straightforward or more restricted, depending on whether it appears in the regular section or the exception section of the List.

The List is updated regularly. What was true a few months ago may have changed.

Does RAMQ cover hormone therapy?

Sometimes yes — but not automatically for every product.

Several hormone treatments used in perimenopause and menopause appear on the List of medications. Others may be subject to particular conditions, or may not be covered in the same way.

An important point in Quebec: in May 2022, the government made access easier for two bioidentical hormones often discussed in the management of menopause symptoms:

• estradiol-17β topical gel
• micronized progesterone

These products, which previously appeared in a more restrictive section, were moved to the regular section of the List, which simplified access for many women.

This does not mean, however, that:

• all bioidentical hormones are covered in the same way
• all patches, gels, or tablets are equivalent in terms of coverage
• a compounded “custom” preparation will be reimbursed like a standardized commercial product

What about local hormone therapy?

Local hormone therapy, including vaginal estrogen treatments, is often considered for genitourinary syndrome of menopause: dryness, discomfort, pain with intercourse, or certain associated urinary symptoms.

Clinically, these local treatments do not replace systemic hormone therapy when more general symptoms are present. In terms of coverage, they should also be verified product by product.

Some local options may be listed and covered under the plan’s conditions; others may be covered differently, or not at all. The pharmacy remains the best place to confirm what applies to your prescription.

Commercial products and compounded preparations

It is useful to distinguish:

• licensed pharmaceutical products, offered in standardized doses
• compounded preparations, made to order in a pharmacy

A compounded preparation is not automatically better covered — nor necessarily reimbursed in the same way — simply because it is described as “bioidentical” or personalized. In many situations, coverage for a compounded preparation differs from coverage for a commercial product listed on the List.

If coverage is an important concern for you, it is worth raising it early with the clinician who is prescribing, as well as with your pharmacy.

What should you check in practice?

Before concluding that a treatment is or is not covered, ask questions such as:

• Does this specific medication appear on the List of medications?
• Is it a regular-list medication or an exception drug?
• Is the prescribed formulation (gel, patch, tablet, local treatment) the one that is covered?
• Do I have private insurance that applies first?
• Would a compounded preparation be covered differently from a commercial product?

Asking the pharmacy to check this before the full prescription is prepared can help avoid surprises.

Key takeaways

• Coverage depends on the specific medication, not just the word “hormone therapy.”
• Some bioidentical options have become easier to access in Quebec, but that does not summarize the entire List of medications.
• Systemic and local hormone therapy should be assessed separately, both clinically and in terms of coverage.
• Your pharmacy remains one of the most reliable sources for confirming coverage of a specific prescription.
• Clear information before starting treatment often helps place this option among the other approaches available.

To conclude

In Quebec, the useful question is not only “is hormone therapy covered?” but rather: is this specific product, in this formulation, covered under my plan? Understanding how the List of medications works — and having the prescription checked at the pharmacy — often turns a vague worry into a clearer answer.

Disclaimer

This article provides general educational information. It does not replace a clinical assessment or advice from a healthcare professional. Coverage conditions can change; always verify with your pharmacy or insurer.

References and further reading

1. Régie de l'assurance maladie du Québec. Connaître les conditions de couverture du régime. https://www.ramq.gouv.qc.ca/fr/citoyens/assurance-medicaments/connaitre-conditions-couverture-regime

2. Régie de l'assurance maladie du Québec. Liste des médicaments. https://www.ramq.gouv.qc.ca/fr/a-propos/liste-medicaments

3. Cabinet du ministre de la Santé et des Services sociaux. (2022, May 25). Amélioration de l'accès dans le Régime général d'assurance médicaments à deux hormones bio-identiques pour traiter les symptômes de la ménopause. https://www.quebec.ca/nouvelles/actualites/details/amelioration-de-lacces-dans-le-regime-general-dassurance-medicaments-a-deux-hormones-bio-identiques-pour-traiter-les-symptomes-de-la-menopause-40626

4. Institut national d'excellence en santé et en services sociaux. Prise en charge des manifestations cliniques liées à la ménopause par l'hormonothérapie. https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/prise-en-charge-des-manifestations-cliniques-liees-a-la-menopause-par-lhormonotherapie.html